Merck (NYSE: MRK) is a top pharmaceutical company coming off a good quarter that shows it is growing its top and bottom lines. Even with that growth, the stock still trades at a fairly modest ...

Let’s set the table for Sunday’s presentation of the lung cancer immunotherapy trial known as HARMONi-2. Last June, Summit Therapeutics created a lot of buzz — and sent its stock surging ...

All Ultiworld Standard and All-Access subscribers will have access to watch the live broadcasts from this year’s Pro Championships, where we will have three games in each broadcasting round. #3 ...

One of those was that it tested using the latest Insider Preview build of Windows, and that this build contained significant optimizations related to branch prediction over extant builds.

Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

To open an image in Preview, double-click on the picture from Finder. Ensure to create a duplicate of your picture before you edit it. That’s because the Preview app automatically saves any changes ...

Merck’s Ebola vaccine offered substantial protection to people vaccinated during the 2018-2020 outbreak in the Democratic Republic of the Congo, with an effectiveness of 84% in those who had ...

Pro-Ject adds balanced connectivity with Pick it Pro MM cartridge to its award-winning Debut PRO Turntable for only $100 more. Are the new changes merely cosmetic or a series of improvements that can ...

C-SPAN’s preview of the first day of the 2024 Democratic National Convention include viewer calls; an interview with Associated Press national politics reporter Meg Kinnard, who provided context ...

Merck will be releasing earnings for the most recent quarter on August 1. Analysts expect Merck will report earnings per share of €2.05. Go here to watch Merck stock price in real-time on ...